Analyst Offers 3 Reasons To Ignore Trump's Comments On Drug Prices By: Benzinga via Benzinga December 07, 2016 at 15:21 PM EST Chris Meekins, an analyst at FBR, was a guest on CNBC's "Halftime Report" segment on Wednesday and offered three reasons why ... Read More >> Related Stocks: Fibria Celulose S.A. HEALTHCARE Nasdaq Biotechnology Ishares ETF